Fort Sheridan Advisors LLC Sangamo Therapeutics, Inc Transaction History

Fort Sheridan Advisors LLC

$526 Million
Q1 2024

A detailed history of Fort Sheridan Advisors LLC transactions in Sangamo Therapeutics, Inc stock. As of the latest transaction made, Fort Sheridan Advisors LLC holds 22,021 shares of SGMO stock, worth $7,927. This represents 0.0% of its overall portfolio holdings.

Number of Shares

22,021

Previous 53,831 59.09%

Holding current value

$7,927

Previous $32,000 56.25%

% of portfolio

0.0%

Previous 0.01%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	SELL	$0.42 - $1.38 $13,360 - $43,897	-31,810 Reduced 59.09%	22,021 $14,000
Q3 2023 Nov 08, 2023	SELL	$0.58 - $1.47 $7,339 - $18,602	-12,655 Reduced 19.03%	53,831 $32,000
Q2 2023 Aug 01, 2023	BUY	$1.11 - $1.74 $9,643 - $15,117	8,688 Added 15.03%	66,486 $86,000
Q1 2023 May 12, 2023	SELL	$1.66 - $3.67 $2,000 - $4,422	-1,205 Reduced 2.04%	57,798 $101,000
Q4 2022 Feb 15, 2023	SELL	$2.77 - $5.07 $41,682 - $76,293	-15,048 Reduced 20.32%	59,003 $185,000

Q3 2022 Nov 09, 2022	SELL	$4.27 - $6.39 $1,396 - $2,089	-327 Reduced 0.44%	74,051 $363,000
Q2 2022 Aug 08, 2022	BUY	$3.28 - $6.21 $1,312 - $2,484	400 Added 0.54%	74,378 $308,000
Q1 2022 May 09, 2022	SELL	$5.23 - $7.82 $4,811 - $7,194	-920 Reduced 1.23%	73,978 $430,000
Q4 2021 Feb 10, 2022	SELL	$7.29 - $10.97 $14,135 - $21,270	-1,939 Reduced 2.52%	74,898 $562,000
Q3 2021 Nov 12, 2021	SELL	$9.01 - $12.01 $7,595 - $10,124	-843 Reduced 1.09%	76,837 $692,000
Q2 2021 Aug 17, 2021	BUY	$10.17 - $12.64 $17,644 - $21,930	1,735 Added 2.28%	77,680 $930,000
Q1 2021 May 17, 2021	BUY	$10.88 - $17.05 $51,919 - $81,362	4,772 Added 6.7%	75,945 $952,000
Q4 2020 Feb 16, 2021	BUY	$9.23 - $18.18 $88,054 - $173,437	9,540 Added 15.48%	71,173 $1.11 Million
Q3 2020 Nov 13, 2020	BUY	$9.38 - $12.48 $163,943 - $218,125	17,478 Added 39.58%	61,633 $582,000
Q2 2020 Aug 14, 2020	BUY	$6.21 - $11.83 $11,674 - $22,240	1,880 Added 4.45%	44,155 $396,000
Q1 2020 May 12, 2020	BUY	$5.05 - $8.85 $73,618 - $129,015	14,578 Added 52.63%	42,275 $269,000
Q4 2019 Feb 14, 2020	BUY	$8.03 - $11.7 $35,091 - $51,129	4,370 Added 18.73%	27,697 $232,000
Q3 2019 Nov 12, 2019	BUY	$9.05 - $12.22 $211,109 - $285,055	23,327 New	23,327 $211,000

Others Institutions Holding SGMO

# of Institutions

138

Shares Held

100M

Call Options Held

35.5K

Put Options Held

65.8K

View Full List

About SANGAMO THERAPEUTICS, INC

Ticker SGMO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 156,552,992
Market Cap $56.4M
Description
Sangamo Therapeutics, Inc., a clinical-stage biotechnology company, focuses on translating science into genomic medicines that transform patients' lives using platform technologies in gene therapy, cell therapy, genome editing, and genome regulation. The company offers zinc finger protein (ZFP), a technology platform for making zinc finger nucle...

More about SGMO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Fort Sheridan Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Fort Sheridan Advisors LLC with notifications on news.

Account

Fort Sheridan Advisors LLC Sangamo Therapeutics, Inc Transaction History